- Report
- May 2024
- 129 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
The Scoliosis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat scoliosis, a condition in which the spine curves abnormally. These drugs are used to reduce pain, improve mobility, and slow the progression of the condition. Common treatments include physical therapy, bracing, and surgery. In some cases, drugs may be prescribed to reduce inflammation and pain.
The Scoliosis Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include Pfizer, Merck, Novartis, and Sanofi. Other players include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more